Filing Flows › Oscar Health (OSCR) › Q2 2026 › vs Q2 2025
Oscar Health (OSCR) Q2 2026 vs Q2 2025 (year over year)
Oscar Health's revenue rose $2.0B (+70%) from $2.9B in Q2 2025 to $4.9B in Q2 2026. Operating margin 8.0% against -8.0% (+16.0 pts).
Oscar Health, Q2 2026: revenue $4.9B (+70% year over year), operating margin 8.0%, net earnings $362M, operating cash flow $2.1B. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Operating margin | 8.0% | -8.0% | +16.0 pts |
| Net margin | 7.4% | -8.0% | +15.4 pts |
| Free cash flow margin | 42.6% | 17.5% | +25.2 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $4.9B | $2.9B | $2.0B | +70% |
| Operating profit | $389M | −$230M | $619M | — |
| Costs & expenses | $4.5B | $3.1B | $1.4B | +45% |
| Pre-tax earnings | $383M | −$234M | $617M | — |
| SG&A | $691M | $534M | $157M | +29% |
| Other operating costs | $3.8B | $2.6B | $1.2B | +48% |
| Net earnings | $362M | −$228M | $590M | — |
| Income tax | $21.2M | −$5.0M | $26.2M | — |
| Depreciation & amortization | $6.0M | $7.0M | −$939K | -13% |
| Share-based compensation | $20.7M | $24.1M | −$3.5M | -14% |
| Working capital & other | $1.7B | $706M | $997M | +141% |
| Operating cash flow | $2.1B | $509M | $1.6B | +311% |
| Free cash flow (OCF − capex) | $2.1B | $500M | $1.6B | +316% |
| Capital expenditures | $11.8M | $9.3M | $2.5M | +27% |
Questions
How much did Oscar Health's revenue grow year over year in Q2 2026?
Oscar Health's revenue rose $2.0B (+70%) from $2.9B in Q2 2025 to $4.9B in Q2 2026. Operating margin 8.0% against -8.0% (+16.0 pts).